Slate Pharmaceuticals' Unattributed VC - II Round

Slate Pharmaceuticals raised a round of funding on September 28, 2010.

Slate currently markets Testopel in the United States. Testopel is an FDA-approved subcutaneous implantable testosterone pellet. Testopel is used for the treatment of testosterone deficiency in aging…

Articles about Slate Pharmaceuticals' Unattributed VC - II Round: